Why the Biobank Market Is Gaining Research Attention
The global biobank market is expanding against a backdrop of rising demand for personalized medicine, growth in genomic research, and increasing investment in biobanking infrastructure. The market was valued at USD 81.62 billion in 2024 and is projected to reach USD 119.0 billion by 2032, registering a CAGR of 4.82% over the forecast period. What makes this market particularly notable is the shift toward decentralized biobanking and the integration of AI and machine learning in data analysis—enhancing research outcomes and enabling researchers to access diverse populations and geographical regions for more representative data.
At a Glance: Biobank Market
-
2023 market size: USD 77.86 billion
-
2024 estimated size: USD 81.62 billion
-
2032 projected size: USD 119.0 billion
-
CAGR (2025–2032): 4.82%
-
Largest application segment: Disease Research (USD 31.0 billion in 2024, projected to reach USD 46.0 billion by 2032)
-
Largest sample type segment: Blood Samples
-
Largest end-user segment: Research Institutes
-
Leading region: North America (USD 30.0 billion in 2024, projected to reach USD 44.0 billion by 2032)
-
Fastest-growing region: Asia Pacific
Increasing Demand for Biomaterials and Biological Samples Drives Growth
The market is experiencing significant growth due to increasing demand for biomaterials and biological samples in various fields such as research, drug development, and personalized medicine. Biobanks serve as critical repositories that collect, store, and distribute biological samples like blood, tissue, and DNA, which are essential for understanding diseases, developing new therapies, and conducting academic and clinical research. As the scientific community continues to explore complex biological processes and diseases, reliance on biobanks will only intensify. The integration of advanced technologies such as genomics and proteomics with biobanking facilitates deeper insights into human health and disease, contributing to personalized healthcare approaches. The expanding prevalence of genetic disorders and chronic diseases fuels the need for comprehensive biorepositories that can provide access to diverse and high-quality biological samples.
Technological Advancements in Biobanking Enhance Efficiency
Technological innovation is a driving force behind market growth. Significant advancements in sample collection, processing, and storage technologies are enhancing the effectiveness and efficiency of biobanks. Automated systems for sample handling minimize human error and increase throughput, while cutting-edge preservation techniques ensure the integrity of biological samples over extended periods. The rise of data analytics and informatics plays a crucial role in managing the vast amounts of data generated by biobanks, enabling researchers to access valuable insights quickly. As technological capabilities improve, biobanks can better meet the evolving needs of researchers and healthcare providers, further boosting market growth.
Growing Investment in Research and Development Supports Expansion
There is a marked increase in investment for research and development across various sectors, significantly impacting the market. Governments, academic institutions, and private organizations are allocating more funds to biomedical research aimed at understanding health and disease. This emphasis on R&D cultivates the need for biological samples, as they are integral to experimental studies, clinical trials, and innovative therapeutic solutions. As investment in research continues to rise, the demand for biobanking services will also grow, establishing a positive correlation between R&D funding and market expansion.
Disease Research Dominates, While Personalized Medicine Gains Traction
In the application segment, Disease Research holds a majority position, valued at USD 31.0 billion in 2024 and projected to climb to USD 46.0 billion by 2032. This illustrates its critical importance in understanding and combating various health issues. Drug Development is also a vital component, valued at USD 25.0 billion in 2024 and expected to reach USD 37.0 billion by 2032, reflecting its role in facilitating the creation of new therapies and medications. Personalized Medicine is gaining traction as it tailors treatments based on individual genetic profiles, marked by a valuation of USD 15.62 billion in 2024, rising to USD 23.0 billion by 2032. Genetic Research, although smaller, is crucial for understanding the complexities of human genetics, with a valuation of USD 10.0 billion in 2024, anticipated to grow to USD 13.0 billion by 2032.
Looking for more in-depth data on the biobank market? Get this report customized with inclusion of custom data sets to suit your exact business needs.
Market Dynamics: Personalized Medicine, Genomics, and Research Funding
Several structural factors are supporting market growth:
-
Increasing demand for personalized medicine and precision therapies.
-
Rising investments in biobanking infrastructure and genomic research.
-
Advancements in biomaterial preservation techniques and automated sample handling.
-
Growing focus on genomic research and the integration of AI in data analysis.
-
Supportive regulatory frameworks for biobanks and biosample collection.
-
Expansion of decentralized biobanking to collect samples from diverse populations.
Biobank Market Outlook, 2025–2035
The market is projected to grow at a 4.82% CAGR from 2025 to 2032, driven by increasing need for personalized medicine and advancements in genomics and biotechnology. New opportunities lie in biobank expansion and technological innovation, integrating AI and machine learning in data analysis, and establishing specialized biobanks for rare diseases. By 2032, the market is expected to reach USD 119.0 billion, with North America maintaining dominance and Asia Pacific emerging as a significant growth region due to increasing emphasis on biotechnology and healthcare advancements.
Key Companies
Companies profiled in the biobank market include:
-
Merck KGaA
-
Illumina
-
Zyagen
-
Beckman Coulter
-
Eurofins Scientific
-
Hamilton Company
-
PerkinElmer
-
Qiagen
-
Stigman
-
GenoLogics
-
Biosample Solutions
-
Thermo Fisher Scientific
-
Corcell
-
VWR International
Explore the full list of profiled companies operating in this market with recent strategic initiatives — View Company Profiles
Explore our dedicated business services:
-
Go-To-Market (GTM) Strategy – Accelerate market entry and maximize ROI with market entry roadmaps, customer segmentation, product-market fit assessment, channel strategy, pricing and positioning, and digital GTM advisory.
-
Deep Dive Competitive Intelligence – Gain 360° visibility on competitors through benchmarking and SWOT analysis, product pipeline tracking, M&A monitoring, and pricing and distribution tracking.
-
Feasibility Assessments – Evaluate the commercial, technical, and operational viability of an initiative before deployment, including demand analysis, regulatory environment assessment, and ROI payback modeling.
-
Granular Research & Custom Insights – Answer specific and complex business questions through segment-level market sizing, micro-regional analysis, niche buyer journey studies, and sub-category demand forecasts.
-
Thought Leadership & Whitepapers – Position your brand as a category leader with data-backed publications and future outlooks.
-
Supply Chain Intelligence – Track suppliers, cost structures, and sourcing dynamics to improve resilience and savings.
-
Data Modeling & Predictive Analytics – Leverage machine learning, statistical forecasting, and econometrics for better planning.
About us:
WiseGuyReports is a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. By offering comprehensive market intelligence, the company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets. WiseGuyReports has a team of experts who blend industry knowledge and cutting-edge research methodologies to provide excellent insights across various sectors. Whether exploring new market opportunities, appraising consumer behavior, or evaluating competitive landscapes, WiseGuyReports offers bespoke research solutions for specific objectives. Accuracy, reliability, and timeliness are the main priorities when preparing deliverables. The company aims to be a trustworthy partner within dynamic business settings through excellence and innovation. WiseGuyReports upholds the power of collaboration, working closely with clients to comprehend their unique concerns, objectives, and goals. Innovation differentiates WiseGuyReports from other companies in the market research industry—the firm adopts new technologies and methodologies as well as best practices to improve capabilities continuously and keep up with upcoming trends. WiseGuyReports (WGR) is part of WiseGuy Research Consultants Pvt. Ltd., founded in 2014 and headquartered in Pune, India.




